Xiaoping Qian
Zhejiang Chinese Medical University(CN)Jiangsu University(CN)Nanjing University of Chinese Medicine(CN)National University of Singapore(SG)Xuzhou Medical College(CN)Cancer Institute (WIA)(IN)Anshun University(CN)Nanjing Traditional Chinese Medicine Hospital(CN)Nanjing Drum Tower Hospital(CN)Jiangsu Cancer Hospital(CN)Yixing People's Hospital(CN)Nanjing Medical University(CN)Nanjing University(CN)
Publications by Year
Research Areas
Nanoparticle-Based Drug Delivery, Immunotherapy and Immune Responses, Colorectal Cancer Treatments and Studies, Genetic factors in colorectal cancer, Nanoplatforms for cancer theranostics
Most-Cited Works
- → 5-Hydroxymethylcytosine signatures in circulating cell-free DNA as diagnostic biomarkers for human cancers(2017)381 cited
- → Intercalated combination of chemotherapy and erlotinib for patients with advanced stage non-small-cell lung cancer (FASTACT-2): a randomised, double-blind trial(2013)304 cited
- Endogenous regulation of angiogenesis in the rat aorta model. Role of vascular endothelial growth factor.(1997)
- → Human cytotoxic T-lymphocyte membrane-camouflaged nanoparticles combined with low-dose irradiation: a new approach to enhance drug targeting in gastric cancer(2017)135 cited
- → Superior antitumor efficiency of cisplatin-loaded nanoparticles by intratumoral delivery with decreased tumor metabolism rate(2008)127 cited
- → Targeted delivery of miR-200c/DOC to inhibit cancer stem cells and cancer cells by the gelatinases-stimuli nanoparticles(2013)126 cited